Coherus BioSciences, Inc. (CHRS)

NASDAQ: CHRS · Real-Time Price · USD

0.9923

+0.0461 (4.87%)

At close: May 8, 2025, 4:00 PM

0.9923

0.00 (0.00%)

Pre-market: May 9, 2025, 8:00 AM EDT

Coherus BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	266.96	257.24	211.04	326.55	475.82	Upgrade
Revenue	266.96	257.24	211.04	326.55	475.82	Upgrade
Revenue Growth (YoY)	3.78%	21.89%	-35.37%	-31.37%	33.63%	Upgrade
Cost of Revenue	117.55	158.99	70.08	57.59	37.67	Upgrade
Gross Profit	149.41	98.25	140.96	268.96	438.16	Upgrade
Selling, General & Admin	150.44	185.62	198.48	169.71	139.08	Upgrade
Research & Development	93.34	105.84	199.36	363.11	142.76	Upgrade
Operating Expenses	243.77	291.45	397.84	532.82	281.84	Upgrade
Operating Income	-94.37	-193.2	-256.88	-263.86	156.32	Upgrade
Interest Expense	-27.16	-40.54	-32.47	-22.96	-21.17	Upgrade
Interest & Investment Income	4.5	2.8	1.9	1.4	0.6	Upgrade
Other Non Operating Income (Expenses)	-1.13	2.67	1.92	-1.68	-0.05	Upgrade
EBT Excluding Unusual Items	-118.15	-228.27	-285.53	-287.1	135.71	Upgrade
Merger & Restructuring Charges	-6.7	-10	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	176.59	-	-	-	-	Upgrade
Asset Writedown	-10.6	-	-	-	-	Upgrade
Other Unusual Items	-12.63	-	-6.22	-	-	Upgrade
Pretax Income	28.51	-238.27	-291.75	-287.1	135.71	Upgrade
Income Tax Expense	-	-0.38	-	-	3.46	Upgrade
Earnings From Continuing Operations	28.51	-237.89	-291.75	-287.1	132.24	Upgrade
Net Income	28.51	-237.89	-291.75	-287.1	132.24	Upgrade
Net Income to Common	28.51	-237.89	-291.75	-287.1	132.24	Upgrade
Net Income Growth	-	-	-	-	47.21%	Upgrade
Shares Outstanding (Basic)	115	94	78	75	71	Upgrade
Shares Outstanding (Diluted)	115	94	78	75	83	Upgrade
Shares Change (YoY)	21.95%	21.30%	2.89%	-9.63%	14.08%	Upgrade
EPS (Basic)	0.25	-2.53	-3.76	-3.81	1.85	Upgrade
EPS (Diluted)	0.25	-2.53	-3.76	-3.81	1.62	Upgrade
EPS Growth	-	-	-	-	31.99%	Upgrade
Free Cash Flow	-20.44	-174.88	-241.12	-38.72	146.91	Upgrade
Free Cash Flow Per Share	-0.18	-1.86	-3.11	-0.51	1.76	Upgrade
Gross Margin	55.97%	38.19%	66.79%	82.36%	92.08%	Upgrade
Operating Margin	-35.35%	-75.10%	-121.72%	-80.80%	32.85%	Upgrade
Profit Margin	10.68%	-92.48%	-138.25%	-87.92%	27.79%	Upgrade
Free Cash Flow Margin	-7.66%	-67.98%	-114.25%	-11.86%	30.88%	Upgrade
EBITDA	-89.09	-189.41	-253.18	-260.4	159.21	Upgrade
EBITDA Margin	-33.37%	-73.63%	-119.97%	-79.74%	33.46%	Upgrade
D&A For EBITDA	5.28	3.79	3.7	3.45	2.89	Upgrade
EBIT	-94.37	-193.2	-256.88	-263.86	156.32	Upgrade
EBIT Margin	-35.35%	-75.10%	-121.72%	-80.80%	32.85%	Upgrade
Effective Tax Rate	-	-	-	-	2.55%	Upgrade
Advertising Expenses	10.9	10.9	10.5	-	3.8	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q